Maximal efficiency is required to minimize complications and hospital stay after TAVR

When TAVR is performed with transfemoral percutaneous approach, local anesthesia, no routine post-procedural intensive care admission, an early discharge (<3 days) can be adopted in most TAVR patients Avoiding peri-procedural complications and minimizing pace-maker implantation rate are key to allow early patient discharge When properly selected, patients discharged early have low discharge have low risk of adverse events and readmissions in the first 30 days.